Related Experiment Video

Updated: Jan 22, 2026

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.4K

Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma

Amanda Thomaz1,2, Kelly de Vargas Pinheiro1,2, Bárbara Kunzler Souza1,2

  • 1Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre, Brazil.

Frontiers in Pharmacology
|July 13, 2019
PubMed

Insights

Selective inhibition of tropomyosin receptor kinase B (TrkB) with ANA-12 demonstrates anticancer effects in medulloblastoma (MB). This approach impairs MB cell proliferation and tumor growth by affecting key cellular pathways and promoting differentiation.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Neurotrophins, including brain-derived neurotrophic factor (BDNF), are crucial for neural development and plasticity.
  • BDNF signaling through tropomyosin receptor kinase B (TrkB) has been linked to various cancers, but its role in medulloblastoma (MB) is not well understood.

Purpose of the Study:

  • To investigate the role of TrkB signaling in medulloblastoma (MB) progression.
  • To evaluate the therapeutic potential of selective TrkB inhibition in MB.

Main Methods:

  • Utilized the small molecule compound ANA-12 for selective TrkB inhibition.
  • Assessed proliferation, viability, apoptosis, and differentiation markers in human MB cell lines (UW228, D283).
  • Evaluated the effects of ANA-12 on MB tumor xenografts in nude mice.

Main Results:

  • TrkB inhibition with ANA-12 significantly impaired MB cell proliferation and viability.
  • ANA-12 treatment slowed MB tumor growth in vivo, increased apoptosis, and reduced extracellular-regulated kinase (ERK) activity.
  • Observed increased signal transducer and activator of transcription 3 (STAT3) expression and differential p21 modulation.
  • ANA-12 induced morphological differentiation, increased β-III Tubulin (TUBB3), and decreased Nestin expression.

Conclusions:

  • Selective TrkB inhibition shows consistent anticancer effects in medulloblastoma (MB).
  • TrkB inhibition modulates intracellular signaling pathways and gene expression involved in tumor progression, apoptosis, and differentiation.
  • Targeting TrkB with compounds like ANA-12 represents a potential therapeutic strategy for MB.
Keywords:
brain tumorbrain-derived neurotrophic factormedulloblastomaneurotrophintropomyosin receptor kinase B

More Related Videos

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.9K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.6K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.4K
Cellular Differentiation00:57

Cellular Differentiation

How does a complex organism such as a human develop from a single cell? It all starts from a single fertilized egg which gives rise to a vast array of cell types, such as nerve cells, muscle cells, and epithelial cells that characterize the adult? Throughout development and adulthood, cellular differentiation leads cells to assume their final morphology and physiology. Differentiation is the process by which unspecialized cells become specialized to carry out distinct functions.
A zygote is a...
5.1K